Cockroach allergy: Understanding complex immune responses to develop novel therapies

Pomés, Anna; Arruda, L. Karla

doi:10.1016/j.molimm.2023.03.001

Cited by 3 publications

(1 citation statement)

References 113 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Recent critical assessments of environmental control strategies for management of allergic disease have yielded conflicting outcomes [2, 3], although the effect of pest control on the initial development of allergy and asthma remains unevaluated. Thus, allergen immunotherapy to GCr [15] is an important goal, but this goal is complicated by at least two scientific obstacles: the complexity of the immune response to GCr allergens, with no clear immunodominant allergens [16], and the fact that GCr allergen extracts in the USA have a highly variable allergen content [7, 17, 18]. A more complete description of GCr allergens in the indoor environment will facilitate progress toward that goal by directing investigators, manufacturers, and regulators to target allergens that are most immunopathogenic.…”

Section: Discussionmentioning

confidence: 99%

Vitellin/Vitellogenin Is an Important Allergen in German Cockroach

Hadiwinarta,

Blank,

Somers

et al. 2024

Int Arch Allergy Immunol

View full text Add to dashboard Cite

Introduction: German cockroach (GCr) aeroallergens are associated with allergic rhinitis and asthma. Vitellogenin (Vg) and vitellin (Vn) are abundant proteins in GCr blood and eggs (including egg cases), respectively, and are possible high molecular mass allergens. Prior efforts to purify Vg/Vn yielded amounts too small for subsequent studies. In this study, we report the affinity purification of Vg/Vn from whole-body defatted GCr powder and determination of the binding of Vg/Vn to anti-GCr IgE. Method: New Zealand white rabbits were immunized with pure Vg/Vn in Freund’s adjuvant, and IgG was purified from the rabbit sera and conjugated to cyanogen bromide (CNBr)-activated Sepharose. Aqueous extracts from GCr powder were passed over the column. After extensive washing, putative Vg/Vn was eluted in low-pH buffer, neutralized, and analyzed by SDS-PAGE and liquid chromatography high-resolution mass spectrometry (LC-HRMS). IgE binding of Vg/Vn was evaluated by inhibition of IgE binding to GCr-ImmunoCAP(I6) in sera from 10 GCr-allergic individuals. In addition, Vg/Vn was biotinylated and bound to ImmunoCAP-streptavidin, and direct IgE antibody binding to the immobilized Vg/Vn was determined in sera from 26 GCr-allergic individuals. Results: Vg/Vn isolated by affinity chromatography was 91% pure by LC-HRMS; contaminants included Bla g 3 (0.9%), human keratin (6%), and rabbit IgG. Vg/Vn inhibited IgE binding to GCr-ImmunoCAP(I6) in 8 of 10 sera. In direct-binding experiments, 21/26 (80%) sera had anti-Vg/Vn IgE at >0.10 kUA/L, while 11/26 (42%) sera were >0.35 kUA/L. Conclusions: We affinity-purified Vg/Vn and demonstrated that Vg/Vn-specific IgE antibody is a major component of GCr-specific IgE.

show abstract